1. Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice

   • Xia Li
   • Alexander F. Hoffman
   • Zheng-Xiong Xi

   Original Investigation 20 December 2008 Pages: 1 - 11

   

2. Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats

   • Gabriel S. Bassi
   • Ana C. Broiz
   • Marcus L. Brandão

   Original Investigation 18 December 2008 Pages: 13 - 24

   

3. 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum

   • F. Joseph McClernon
   • Rachel V. Kozink
   • Jed E. Rose

   Original Investigation 24 December 2008 Pages: 25 - 35

   

4. WAY-163909, a 5-HT_2C agonist, enhances the preclinical potency of current antipsychotics

   • Steven M. Grauer
   • Radka Graf
   • Sharon Rosenzweig-Lipson

   Original Investigation 20 December 2008 Pages: 37 - 48

   

5. Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice

   • Sarah Jane Harrison
   • José N. Nobrega

   Original Investigation 19 December 2008 Pages: 49 - 59

   

6. Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups

   • Aki Takahashi
   • Jasmine J. Yap
   • Klaus A. Miczek

   Original Investigation 20 December 2008 Pages: 61 - 71

   

7. Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD)

   • Scott H. Kollins
   • Joseph English
   • Allan K. Chrisman

   Original Investigation 23 December 2008 Pages: 73 - 83

   

8. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)

   • Claudine C. Hunault
   • Tjeert T. Mensinga
   • Jan Meulenbelt

   Original Investigation 20 December 2008 Pages: 85 - 94

   

9. Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice

   • Roopashree Narasimhaiah
   • Helen M. Kamens
   • Marina R. Picciotto

   Original Investigation 20 December 2008 Pages: 95 - 102

   

10. The adenosine A_2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

    • Allison M. Mott
    • Eric J. Nunes
    • John D. Salamone

    Original Investigation 09 January 2009 Pages: 103 - 112

    

11. A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam

    • Carlo Cifani
    • Carlo Polidori
    • Maurizio Massi

    Original Investigation 06 January 2009 Pages: 113 - 125

    

12. Novice drivers’ performance after different alcohol dosages and placebo in the divided-attention steering simulator (DASS)

    • Joris C. Verster
    • Anne E. Wester
    • Edmund R. Volkerts

    Original Investigation Open access 06 January 2009 Pages: 127 - 133

    

13. Increased operant responding for ethanol in male C57BL/6J mice: specific regulation by the ERK_1/2, but not JNK, MAP kinase pathway

    • Sara Faccidomo
    • Joyce Besheer
    • Clyde W. Hodge

    Original Investigation 06 January 2009 Pages: 135 - 147

    

14. Positron emission tomographic measure of brain dopamine dependence to nicotine as a model of drugs of abuse

    • Edward F. Domino
    • Hideo Tsukada
    • Norihiro Harada

    Original Investigation 10 January 2009 Pages: 149 - 153

    

15. Nicotine withdrawal and reward responsivity in a card-sorting task

    • Natasha Kalamboka
    • Bob Remington
    • Steven Glautier

    Original Investigation 17 January 2009 Pages: 155 - 163

    

16. Amphetamine effects on startle gating in normal women and female rats

    • Jo A. Talledo
    • Ashley N. Sutherland Owens
    • Neal R. Swerdlow

    Original Investigation Open access 16 January 2009 Pages: 165 - 175

    

17. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

    • Xiang Yang Zhang
    • Dong Feng Zhou
    • Thomas R. Kosten

    Original Investigation 13 January 2009 Pages: 177 - 184

18. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

    • Melanie A. Paquette
    • Katherine Foley
    • S. Paul Berger

    Erratum 01 April 2009 Pages: 185 - 187

    

19. Drug context differently regulates cocaine versus heroin self-administration and cocaine- versus heroin-induced Fos mRNA expression in the rat

    • Michele Celentano
    • Daniele Caprioli
    • Aldo Badiani

    Erratum 04 April 2009 Pages: 189 - 189